Characteristics of Preapproval and Postapproval Studies of Vaccines Granted Accelerated Approval by the US Food and Drug Administration
- 15 June 2021
- journal article
- letter
- Published by Springer Science and Business Media LLC in Journal of General Internal Medicine
- Vol. 36 (10), 3281-3284
- https://doi.org/10.1007/s11606-021-06943-x
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Speed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug AdministrationJAMA Internal Medicine, 2021
- Ethical and Scientific Considerations Regarding the Early Approval and Deployment of a COVID-19 VaccineAnnals of Internal Medicine, 2021
- Emergency Approvals for COVID-19: Evolving Impact on Obligations to Patients in Clinical Care and ResearchAnnals of Internal Medicine, 2021
- Characteristics of Preapproval and Postapproval Studies for Drugs Granted Accelerated Approval by the US Food and Drug AdministrationJAMA, 2017
- Clinical Trial Evidence Supporting FDA Approval of Novel Therapeutic Agents, 2005-2012JAMA, 2014